FDG-PET Biomarker Ctte

Quantitative FDG-PET Technical Committee Mission

• Mission; Foster adoption of ...
  • pragmatic and cost effective standards for
  • accurate and reproducible
  • longitudinal
  • quantitation of
  • biologic parameters
  • with clinical relevance
  • and known sigma

• "Why QIBA?" - Specifics associated with PET-CT device and software manufacturers.

Meetings / Call Summaries

• Monthly FDG-PET Call Summaries

Profile Development

Drafting:

• Whole Body FDG-PET Word version of Profile applicable to multiple indications, 01-31-2011

Archive:

• Profile: FDG-PET Whole Body First version of Profile, 2009 (currently inactive)

Working Documents and Reference Materials

• Covariates Rationale
• Standardized Uptake Value (SUV)
• Quality Control Metrics
• ROI Definition
• Software Version Tracking

• Covariates Rationale SubCtte March 2009
• Digital Reference Objects SubCtte March 2009
• Quality Control Metrics SubCtte March 2009
• Region of Interest SubCtte March 2009
• Software Version Tracking SubCtte March 2009

• NL Standardization Protocol for Quantitative FDG-PET in multi-Center Trials - Dr Ronald Boellaard

The Netherlands Standardization Protocol for Quantitative FDG-PET in Multi-center Trials (English translation of Version 1)

Please keep the following in mind:

The development of this protocol was started about 2005 and approved more than 1 year ago in The Netherlands (NL). However, with gained insight, changes are scheduled to be incorporated in the next version by 2010. The following changes will be made (consider them being applied already or underway):

• Use of oral contrast is now excluded but will be allowed in the next version
• We are currently working on standards for CT as well, including GL for doing CT-QC (in cooperation with the radiologists/radiology societies in NL)
• There will be an upper limit for dosage
• We are working on traceable/calibrated and mutually linked sources for both PET and the dose calibrator and these will be used for absolute (rather than cross-) calibration (but in addition to the cross-calibration using FDG).
• Reconstruction settings given in the protocol are indicative and are likely not applicable for future scanners and software upgrades. Therefore reconstruction parameters should be set such that they provide results that meet the specifications given for the multi-center QC experiments. Same settings should then be applied to patient studies (see also comments under "execptions/special features” and comments made in the paper by Boellaard et al. EJNMMI 2008).
• Various other minor edits/typos/changes

The protocol is not a step-by-step description of the logistics for doing a PET/CT study. However, it has been set up in a somewhat chronological order and may thus be used to populate (copy-paste) such a step-by-step description. Additional work required ... FDG-PET/CT Technical Committee input is highly appreciated.

Submitted by Ronald Boellaard, PhD

• From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

Submitted by Richard L. Wahl, MD and Martin A. Lodge, PhD

• 05.19.2009 QIBA FDG-PET/CT Breakout Session Notes

• Draft FDG-PET ICL Logistics Outline

Submitted by Eric S. Perlman, MD

• Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction - Radiology 1999; 213: 521-525

Slide Presentations

• QIBA Informational Meeting (Dec 1st at RSNA 2008) - Slide Content Review
• QIBA Working Meeting (Dec 4th at RSNA 2008) - FDG-PET/CT Breakout Session Slide Deck
• Fused Images
• Media:FDG-PET11-29.ppt
• QIBA FDG-PET/CT Mission Statement - 2009.03.10
• QIBA Profiling Process-03.31.2009 (Andrew Buckler, MS)
• FDG-PET/CT Technical Committee summary 2009.05.20 Richard Frank